共 4 条
- [2] Market control of the French Health Products Safety Agency on 21 in vitro diagnostic medical devices measuring estradiol: technical performances and conformity to the regulations mentions IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2007, 22 (02): : 125 - 134
- [3] Rapid antigen detection tests for diagnosis of group A streptococcal pharyngitis:: Comparative evaluation of sensitivity and practicability of 16 in vitro diagnostic medical devices performed in July 2002 by the French health products safety agency (Afssaps) as part of its market control mission PATHOLOGIE BIOLOGIE, 2004, 52 (08): : 438 - 443
- [4] Sigma metrics for assessing the analytical quality of the new multi-test VITROS® XT chemistry products slides11*For presentation and demonstration purposes only. VITROS XT Slides are currently under development and are not available to the public or for sale until approved under the requirements of the DIRECTIVE 98/79/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 October 1998 on in vitro diagnostic medical devices and the respective regulatory requirements of the target market CLINICA CHIMICA ACTA, 2019, 493 : S503 - S504